Global Multiple Sclerosis Therapeutics Market is estimated to be US$ 30.62 billion by 2030 with a CA

Author : NISHA SHAHA | Published On : 11 Oct 2021

The Global Multiple Sclerosis Therapeutics Market accounted for US$ 24.03 billion in 2020 and is estimated to be US$ 30.62 billion by 2030 and is anticipated to register a CAGR of 2.50%. Herbal medicine (also herbalism) is that the study of pharmacognosy and therefore the use of medicinal plants, which are a basis of traditional medicine. There is limited scientific evidence for the security and efficacy of plants utilized in 21st century herbalism, which generally doesn't provide standards for purity or dosage. The scope of herbal medicine commonly includes fungal and bee products, also as minerals, shells and certain animal parts. Herbal medicine is additionally called phytomedicine or phytotherapy.

The report “Global Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Key Highlights:

  • In 2021, U.S. FDA approves J&J's multiple sclerosis treatment; launch in April. (Reuters) - Johnson & Johnson will launch its newly approved drug for adults with relapsing multiple sclerosis (MS) in the United States in early April 2021 at a similar price point to rival treatments.

Analyst View:

Currently, there is no cure for MS however; number of treatment can help to control the condition. Treatment modalities are depends on specific symptoms and difficulties of patient, which includes treating relapses with short courses of steroid medication, disease modifying therapies, and specific treatments for individual MS symptoms. Increasing prevalence of multiple sclerosis among the global population, along with extensive research and development (R&D) activities undertaken by key players and government research organizations will accelerate the market growth.

Browse 60 maret data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Multiple-Sclerosis-Therapeutics-Market-54

Key Market Insights from the report:

The Global Multiple Sclerosis Therapeutics Market accounted for US$ 24.03 billion in 2020 and is estimated to be US$ 30.62 billion by 2030 and is anticipated to register a CAGR of 2.50%. The global multiple sclerosis therapeutics market has been segmented on the basis of drug class, route of administration, distribution channel, and region.

  • By Drug Class, the Global Multiple Sclerosis Therapeutics Market is segmented into Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents, and Others.
  • By Route of Administration, the Global Multiple Sclerosis Therapeutics Market is segmented into Oral and Injectable.
  • By Distribution Channel, the Global Multiple Sclerosis Therapeutics Market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
  • By region, the Global Multiple Sclerosis Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the multiple sclerosis therapeutics market. Factors responsible for growth of the market includes substantial rise in the awareness among the people regarding various risk factors to cause multiple sclerosis.

Competitive Landscape:

Key players operating in the global multiple sclerosis therapeutics market includes Bayer AG, Teva Pharmaceutical Industries Ltd., Novartis AG, Merck KGaA, Biogen Inc., Sanofi S.A., F. Hoffmann-La Roche AG, AbbVie, Inc., and Pfizer, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

  1. Introduction
  • Study Deliverables
  • Study Assumptions
  • Scope of the Study
  1. Research Methodology
  2. Executive Summary
  • Opportunity Map Analysis
  • Market at Glance
  • Market Share (%) and BPS Analysis, by Region
  • Competitive Landscape
  • Heat Map Analysis 
  • Market Presence and Specificity Analysis
  1. Investment Analysis
  2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com